Menu

• Ask a Health Expert about ANTITHROMBIN III DECREASED
• Post Your Side Effect related to ANTITHROMBIN III DECREASED
• ANTITHROMBIN III DECREASED and FDA Warnings
• ANTITHROMBIN III DECREASED in Patients Wiki
• Report ANTITHROMBIN III DECREASED in Drug Side Effect Survey

ANTITHROMBIN III DECREASED side effect

What is ANTITHROMBIN III DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Oncaspar Side Effects Report #5664088-2
Physician from UNITED STATES reported ONCASPAR problem on Feb 28, 2008. Female patient, weighting 31.31 lb, was diagnosed with acute lymphocytic leukaemia and was treated with ONCASPAR. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, cerebral artery occlusion, cerebral ischaemia, cerebrovascular accident, protein s decreased, . ONCASPAR dosage: unknown. During the same period patient was treated with CEFTAZIDIME, PREDNISONE, PEPCID, DIFLUCAN, BACTRIM. Patient was hospitalized. Patient recovered.

Effexor Side Effects Report #5477718-5
EFFEXOR problem was reported by a Health Professional from FRANCE on Sept 25, 2007. Female patient, weighting 81.57 lb, was diagnosed with depression and was treated with EFFEXOR. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, blood lactate dehydrogenase increased, c-reactive protein increased, coagulation factor v level decreased, cytolytic hepatitis, dyspnoea, fibrin d dimer increased, gamma-glutamyltransferase increased, . EFFEXOR dosage: 50 MG 3 TIMES PER DAY AND THEN DOSE REDUCED. During the same period patient was treated with AMOXICILLIN, AUGMENTIN, DIGOXIN, RISPERDAL, AMLOR, KALEORID, KARDEGIC, XANAX. Patient was hospitalized. Patient died on 08/21/2007.

Neoral Side Effects Report #5404791-2
Consumer or non-health professional from JAPAN reported NEORAL problem on July 26, 2007. Female patient, child 7 years of age, weighting 55.12 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, carotid artery stenosis, carotid artery thrombosis, cerebral infarction, disease recurrence, dysarthria, hypercoagulation, hypoalbuminaemia, muscle spasms, . NEORAL dosage: 160 MG/D. During the same period patient was treated with PREDONINE, BONALON, ALFAROL. Patient was hospitalized. Patient recovered.

Neoral Side Effects Report #5404793-6
NEORAL problem was reported by a Consumer or non-health professional from JAPAN on July 26, 2007. Female patient, child 7 years of age, weighting 55.12 lb, was diagnosed with nephrotic syndrome and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, carotid artery stenosis, carotid artery thrombosis, cerebral infarction, disease recurrence, dysarthria, hypercoagulation, hypoalbuminaemia, muscle spasms, . NEORAL dosage: 160 MG/D. During the same period patient was treated with PREDONINE, BONALON, ALFAROL. Patient was hospitalized. Patient recovered.


Cyclosporine Side Effects Report #5381639-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on June 27, 2007. Female patient, child 7 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, cerebral infarction, hypoalbuminaemia, nephropathy toxic, . CYCLOSPORINE dosage: unknown. Patient recovered.

Cyclosporine Side Effects Report #5387232-3
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on July 03, 2007. Female patient, child 7 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, cerebral infarction, hypercoagulation, hypoalbuminaemia, muscular weakness, nephropathy toxic, nephrotic syndrome, proteinuria, speech disorder, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5404268-4
Consumer or non-health professional from FRANCE reported VINCRISTINE problem on July 17, 2007. Male patient was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, pancreatitis, . VINCRISTINE dosage: 2 MG WEEKLY IV. During the same period patient was treated with KIDROLASE, ZAVEDOS, CORTANCYL MFR, ATARAX, ANTALVIC, TOPALGIC, METHOTREXATE. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5381639-6
CYCLOSPORINE problem was reported by a Consumer or non-health professional from JAPAN on June 27, 2007. Female patient, child 7 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, cerebral infarction, hypoalbuminaemia, nephropathy toxic, . CYCLOSPORINE dosage: unknown. Patient recovered.

Cyclosporine Side Effects Report #5387232-3
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on July 03, 2007. Female patient, child 7 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, cerebral infarction, hypercoagulation, hypoalbuminaemia, muscular weakness, nephropathy toxic, nephrotic syndrome, proteinuria, speech disorder, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with STEROIDS NOS. Patient was hospitalized. Patient recovered.


Vincristine Side Effects Report #5404268-4
VINCRISTINE problem was reported by a Consumer or non-health professional from FRANCE on July 17, 2007. Male patient was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, pancreatitis, . VINCRISTINE dosage: 2 MG WEEKLY IV. During the same period patient was treated with KIDROLASE, ZAVEDOS, CORTANCYL MFR, ATARAX, ANTALVIC, TOPALGIC, METHOTREXATE. Patient was hospitalized. Patient recovered.

Microgestin Side Effects Report #5352336-8
Pharmacist from UNITED STATES reported MICROGESTIN problem on June 07, 2007. Female patient, 17 years of age, was treated with MICROGESTIN. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, deep vein thrombosis, factor v leiden mutation, . MICROGESTIN dosage: unknown. During the same period patient was treated with VICODIN. Patient was hospitalized. Patient recovered.

Voltaren Side Effects Report #5683952-1
VOLTAREN problem was reported by a Physician from JAPAN on Mar 17, 2008. Male patient, 42 years of age, was diagnosed with testicular neoplasm and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, antithrombin iii decreased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood pressure decreased, blood sodium decreased, blood urea increased, . VOLTAREN dosage: 50 MG/ DAY. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5531606-4
Health Professional from JAPAN reported CYCLOSPORINE problem on Nov 26, 2007. Male patient, 16 years of age, weighting 112.4 lb, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, antithrombin iii decreased, blood albumin decreased, blood fibrinogen increased, colitis ischaemic, diarrhoea haemorrhagic, fibrin d dimer increased, nephrotic syndrome, oedema peripheral, . CYCLOSPORINE dosage: 4-5 MG/KG/DAY. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, MIZORIBINE, HEPARIN. Patient was hospitalized. Patient recovered.

Heparin Side Effects Report #5570005-6
HEPARIN problem was reported by a Physician from IRELAND on Dec 05, 2007. Male patient, 60 years of age, was diagnosed with preoperative care, deep vein thrombosis and was treated with HEPARIN. After drug was administered, patient experienced the following problems/side effects: anaemia, antithrombin iii decreased, coagulation factor vii level decreased, coagulation factor x level decreased, deep vein thrombosis, disease recurrence, factor ix deficiency, gangrene, haematuria, . HEPARIN dosage: unknown. During the same period patient was treated with WARFARIN, ANTICOAGULANTS. Patient was hospitalized. Patient recovered.


Cyclosporine Side Effects Report #5577625-3
Health Professional from JAPAN reported CYCLOSPORINE problem on Dec 21, 2007. Male patient, 16 years of age, weighting 112.4 lb, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, antithrombin iii decreased, blood albumin decreased, blood fibrinogen increased, colitis ischaemic, diarrhoea haemorrhagic, fibrin d dimer increased, nephrotic syndrome, oedema peripheral, . CYCLOSPORINE dosage: 4-5 MG/KG/DAY. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, MIZORIBINE, HEPARIN. Patient was hospitalized. Patient recovered.

Gleevec Side Effects Report #5479233-1
GLEEVEC problem was reported by a Consumer or non-health professional from GERMANY on Oct 01, 2007. Male patient, 62 years of age, weighting 176.4 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, antithrombin iii decreased, arteriogram coronary abnormal, biopsy, blood bilirubin increased, blood creatinine increased, blood fibrinogen increased, blood lactic acid increased, chest pain, . GLEEVEC dosage: 400 MG/DAY. During the same period patient was treated with RAMIPRIL, PANTOPRAZOLE, TORSEMIDE, NEBILET, INSULIN, PROTAPHAN. Patient was hospitalized. Patient recovered.

Voltaren Side Effects Report #5754106-5
Physician from JAPAN reported VOLTAREN problem on May 29, 2008. Male patient, weighting 160.9 lb, was diagnosed with testicular neoplasm, pyrexia and was treated with VOLTAREN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, antithrombin iii decreased, anuria, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood pressure decreased, blood sodium decreased, . VOLTAREN dosage: 50 MG/ DAY. Patient recovered.

Tegretol Side Effects Report #5361603-3
TEGRETOL problem was reported by a Health Professional from GERMANY on June 14, 2007. Female patient, weighting 106.0 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, antithrombin iii decreased, aspartate aminotransferase increased, asthenia, b-cell lymphoma stage iii, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopulmonary aspergillosis, capillary leak syndrome, . TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with CYTARABINE, NOXAFIL, RITUXIMAB, CISPLATIN, DEXAMETHASONE, CARMUSTINE, ETOPOSIDE. Patient was hospitalized. Patient died on 01/02/2007.

Tegretol Side Effects Report #5324824-1
Physician from GERMANY reported TEGRETOL problem on May 11, 2007. Female patient, weighting 106.0 lb, was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, antithrombin iii decreased, aspartate aminotransferase increased, asthenia, b-cell lymphoma stage iii, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopulmonary aspergillosis, . TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with NOXAFIL, RITUXIMAB, CISPLATIN, DEXAMETHASONE, CARMUSTINE, ETOPOSIDE. Patient was hospitalized. Patient died on 01/02/2007.


Cytarabine Side Effects Report #5315652-1
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Female patient, weighting 56.22 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, antithrombin iii decreased, ascites, cardiac failure congestive, disseminated intravascular coagulation, ejection fraction decreased, fluid overload, hepatic failure, hypotension, . CYTARABINE dosage: 7840 MG (980 MG IV Q12 HRS X 4 DAYS). During the same period patient was treated with MYLOTARG. Patient was hospitalized. Patient recovered.

Tegretol Side Effects Report #5522336-3
Health Professional from GERMANY reported TEGRETOL problem on Nov 15, 2007. Female patient, weighting 106.0 lb, was diagnosed with grand mal convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, antithrombin iii decreased, aspartate aminotransferase increased, asthenia, b-cell lymphoma stage iii, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopulmonary aspergillosis, . TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with CYTARABINE, NOXAFIL, RITUXIMAB, CISPLATIN, DEXAMETHASONE, CARMUSTINE, ETOPOSIDE. Patient was hospitalized. Patient died on 01/02/2007.

Tegretol Side Effects Report #5522442-3
TEGRETOL problem was reported by a Health Professional from GERMANY on Nov 15, 2007. Female patient, weighting 106.0 lb, was diagnosed with grand mal convulsion and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, antithrombin iii decreased, aspartate aminotransferase increased, asthenia, b-cell lymphoma stage iii, blood bilirubin increased, blood lactate dehydrogenase increased, bronchopulmonary aspergillosis, . TEGRETOL dosage: 200 MG/DAY. During the same period patient was treated with CYTARABINE, NOXAFIL, RITUXIMAB, CISPLATIN, DEXAMETHASONE, CARMUSTINE, ETOPOSIDE. Patient was hospitalized. Patient died on 01/02/2007.

Omniscan Side Effects Report #5523429-7
Consumer or non-health professional from NORWAY reported OMNISCAN problem on Nov 09, 2007. Male patient, 72 years of age, was diagnosed with peripheral arterial occlusive disease and was treated with OMNISCAN. After drug was administered, patient experienced the following problems/side effects: anaemia, anorexia, antithrombin iii decreased, apathy, blood glucose increased, cardiac failure, cardiac murmur, confusional state, . OMNISCAN dosage: 125 ML, SINGLE DOSE, I.V. ; 150 ML, SINGLE DOSE, I.V. ; 90 ML, SINGLE DOSE, I.V.. During the same period patient was treated with ERYTHROPOETIN, WARFARIN. Patient was hospitalized. Patient died on 04/09/2006.